Such enthusiastic announcements made us expect to find higher levels of LOX-1 in people with stroke, after a myocardial infarction or with obesity, but no such association was found in our geriatric population, perhaps due to a small enough study group or a too-high degree of atherosclerosis in the entire study group. Here, OLR1 is linked to obesity due to melanocortin 4 receptor deficiency.